{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:34:29Z","timestamp":1788327269703,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,7,1]],"date-time":"1999-07-01T00:00:00Z","timestamp":930787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[1999,7]]},"DOI":"10.1023\/a:1018975414165","type":"journal-article","created":{"date-parts":[[2003,2,19]],"date-time":"2003-02-19T17:07:13Z","timestamp":1045674433000},"page":"1010-1019","source":"Crossref","is-referenced-by-count":21,"title":["Biorecognition of HPMA Copolymer-Adriamycin Conjugates by Lymphocytes Mediated by Synthetic Receptor Binding Epitopes"],"prefix":"10.1007","volume":"16","author":[{"given":"Vladimir","family":"Omelyanenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavla","family":"Kope\u010dkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh K.","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jind\u0159ich","family":"Kope\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"303616_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/3540587888_14","volume":"122","author":"D. Putnam","year":"1995","unstructured":"D. Putnam and J. Kope\u010dek. Polymer conjugates with anticancer activity. Adv. Polym. Sci.\n122:55\u2013123 (1995).","journal-title":"Adv. Polym. Sci."},{"key":"303616_CR2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/bc00017a001","volume":"3","author":"H. Maeda","year":"1992","unstructured":"H. Maeda, L. M. Seymour, and Y. Miyamoto. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjugate Chem.\n3:351\u2013362 (1992).","journal-title":"Bioconjugate Chem."},{"key":"303616_CR3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0304-4165(86)90120-0","volume":"880","author":"R. Duncan","year":"1986","unstructured":"R. Duncan, L. C. W. Seymour, L. Scarlett, J. B. Lloyd, P. Rejmanov\u00e1, and J. Kope\u010dek. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats. Biochim. Biophys. Acta\n880:62\u201371 (1986).","journal-title":"Biochim. Biophys. Acta"},{"key":"303616_CR4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0090-1229(88)90010-4","volume":"46","author":"B. \u0158\u00edhov\u00e1","year":"1988","unstructured":"B. \u0158\u00edhov\u00e1, P. Kope\u010dkov\u00e1, J. Strohalm, P. Rossmann, V. V\u011btvi\u010dka, and J. Kope\u010dek. Antibody directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibody. Clin. Immunol. Immunopathol.\n46:100\u2013114 (1988).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"303616_CR5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/10611869608996827","volume":"3","author":"V. Omelyanenko","year":"1996","unstructured":"V. Omelyanenko, P. Kope\u010dkov\u00e1, C. Gentry, J.-G. Shiah, and J. Kope\u010dek. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. Influence of the methods of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. J. Drug Target.\n3:357\u2013373 (1996).","journal-title":"J. Drug Target."},{"key":"303616_CR6","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/ja953729u","volume":"118","author":"G. B. Sigal","year":"1996","unstructured":"G. B. Sigal, M. Mammen, G. Dahman, and G. M. Whitesides. Polyacrylamides bearing pendant sialoside groups strongly inhibit agglutination of erythrocytes by influenza virus: The strong inhibition reflects enhanced binding through cooperative polyvalent interactions. J. Am. Chem. Soc.\n118:3789\u20133800 (1996).","journal-title":"J. Am. Chem. Soc."},{"key":"303616_CR7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/macp.1997.021980418","volume":"198","author":"R. C. Rathi","year":"1997","unstructured":"R. C. Rathi, P. Kope\u010dkov\u00e1, and J. Kope\u010dek. Biorecognition of sugar containing N-(2-hydroxypropyl)methacrylamide copolymers by immobilized lectin. Macromol. Chem. Phys.\n198:1165\u20131180 (1997).","journal-title":"Macromol. Chem. Phys."},{"key":"303616_CR8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1073\/pnas.94.5.1663","volume":"94","author":"A. V. Tersikh","year":"1997","unstructured":"A. V. Tersikh, J.-M. Le Doussal, R. Crameri, I. Fisch, J.-P. Mach, and A. V. Kajava, \u201cPetabody\u201d: A new type of high avidity binding protein. Proc. Natl. Acad. Sci. USA\n94:1663\u20131668 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303616_CR9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/jnci\/81.8.570","volume":"81","author":"R. K. Jain","year":"1989","unstructured":"R. K. Jain, Delivery of novel therapeutic agents in tumors: physiological barriers and strategies. J. Natl. Cancer Inst.\n81:570\u2013576 (1989).","journal-title":"J. Natl. Cancer Inst."},{"key":"303616_CR10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156856294X00040","volume":"5","author":"N. L. Krinick","year":"1994","unstructured":"N. L. Krinick, Y. Sun, D. Joyner, J. D. Spikes, R. C. Straight, and J. Kope\u010dek. A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and\/or light. J. Biomat. Sci., Polym. Ed.\n5: 303\u2013324 (1994).","journal-title":"J. Biomat. Sci., Polym. Ed."},{"key":"303616_CR11","unstructured":"J.-G. Shiah, Y. Sun, P. Kope\u010dkov\u00e1, M. Peterson, and J. Kope\u010dek. Biodistribution in tumor bearing mice of free and HPMA copolymer-bound meso-chlorin e6 and adriamycin. 25th Int. Symposium on Controlled Release of Bioactive Materials, Las Vegas, Nevada, June 21\u201324, 1998. Proceedings, pp. 95\u201396."},{"key":"303616_CR12","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","volume":"95","author":"S. K. Hobs","year":"1998","unstructured":"S. K. Hobs, W. L. Monsky, F. Yuan, W. G. Roberts, L. Griffith, V. P. Torchilin, and R. K. Jain. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc. Natl. Acad. Sci. USA\n95:4607\u20134612 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"303616_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0092-8674(89)90240-7","volume":"56","author":"G. R. Nemerow","year":"1989","unstructured":"G. R. Nemerow, R. A. Houghten, M. D. Moore, and N. R. Cooper. Identification of an epitope in the major envelope protein of Epstein-Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2). Cell\n56:369\u2013377 (1989).","journal-title":"Cell"},{"key":"303616_CR14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.173.4.971","volume":"173","author":"D. Watry","year":"1991","unstructured":"D. Watry, J. A. Hedrick, S. Siervo, G. Rhodes, J. J. Lamberti, J. D. Lambris, and C. D. Tsoukas. Infection of human thymocytes by Epstein-Barr virus. J. Exp. Med.\n173:971\u2013980 (1991).","journal-title":"J. Exp. Med."},{"key":"303616_CR15","first-page":"81","volume-title":"Controlled Drug Delivery","author":"J. Kope\u010dek","year":"1983","unstructured":"J. Kope\u010dek and P. Rejmanov\u00e1. Enzymatically degradable bonds in synthetic polymers. In S. D. Bruck (ed.), Controlled Drug Delivery, CRC Press, Boca Raton, Florida, 1983, vol. I, pp. 81\u2013124."},{"key":"303616_CR16","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1002\/macp.1983.021841006","volume":"184","author":"P. Rejmanov\u00e1","year":"1983","unstructured":"P. Rejmanov\u00e1, J. Pohl, M. Baudy\u0161, V. Kostka, and J. Kope\u010dek. Polymers containing enzymatically degradable bonds. 8. Degradation of oligopeptide sequences in N-(2-hydroxypropyl)methacrylamide copolymers by bovine spleen cathepsin B. Makromol. Chem.\n184:2009\u20132020 (1983).","journal-title":"Makromol. Chem."},{"key":"303616_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/978-1-4613-2745-5_4","volume-title":"Recent Advances in Drug Delivery Systems","author":"J. Kope\u010dek","year":"1984","unstructured":"J. Kope\u010dek. Synthesis of tailor-made soluble polymeric carriers. In J. M. Anderson, S. W. Kim (eds.), Recent Advances in Drug Delivery Systems, Plenum Press, New York, NY, 1984, pp. 41\u201362."},{"key":"303616_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0022-1759(89)90397-9","volume":"119","author":"M. B. Hansen","year":"1989","unstructured":"M. B. Hansen, S. E. Nielsen, and K. Berg. Re-examination and further development of a precise and rapid dye method for measuring cell growing\/cell kill. J. Immunol. Meth.\n119:203\u2013210 (1989).","journal-title":"J. Immunol. Meth."},{"key":"303616_CR19","first-page":"374","volume":"19","author":"G. C. Salzman","year":"1975","unstructured":"G. C. Salzman, J. M. Growell, J. C. Martin, et al. Cell identification by laser light scattering: Identification and separation of unstained leukocyte. Acta Cytol. (Praha)\n19:374\u2013377 (1975).","journal-title":"Acta Cytol. (Praha)"},{"key":"303616_CR20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0022-1759(95)00072-I","volume":"184","author":"I. Vermes","year":"1995","unstructured":"I. Vermes, C. Haanen, H. Steffens-Nakken, and C. Reutelingsperger. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using labeled Annexin V. J. Immun. Methods\n184:39\u201351 (1995).","journal-title":"J. Immun. Methods"},{"key":"303616_CR21","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1073\/pnas.82.12.4235","volume":"82","author":"J. D. Lambris","year":"1985","unstructured":"J. D. Lambris, V. S. Ganu, S. Hirani, and H. J. Muller-Eberhard. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. Proc. Natl. Acad. Sci. U.S.A.\n82:4235\u20134239 (1985).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"303616_CR22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(87)90216-9","volume":"50","author":"J. Tanner","year":"1987","unstructured":"J. Tanner, J. Weis, D. Fearon, Y. Whang, and E. Kieff. Epstein-Barr virus gp350\/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis. Cell\n50:203\u2013213 (1987).","journal-title":"Cell"},{"key":"303616_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0167-5699(93)90059-T","volume":"14","author":"C. D. Tsoukas","year":"1993","unstructured":"C. D. Tsoukas and J. D. Lambris. Expression of EBV\/C3d receptors on T cells. Immunology Today\n14:56\u201359 (1993).","journal-title":"Immunology Today"},{"key":"303616_CR24","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.146.3.865","volume":"146","author":"E. Fischer","year":"1991","unstructured":"E. Fischer, C. Delibrias, and M. D. Kazatchkine. Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes. J. Immunol.\n146:865\u2013869 (1991).","journal-title":"J. Immunol."},{"key":"303616_CR25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1099\/0022-1317-71-2-379","volume":"71","author":"G. Sauvageau","year":"1990","unstructured":"G. Sauvageau, R. Stocco, S. Kasparian, and J. Menezes. Epstein-Barr virus receptor expression on human CD8+ (cytotoxic\/suppressor) T lymphocytes. J. Gen. Virol.\n71:379\u2013386 (1990).","journal-title":"J. Gen. Virol."},{"key":"303616_CR26","first-page":"153","volume":"25","author":"R. Rask","year":"1988","unstructured":"R. Rask, J. M. Rasmussen, H. V. Hansen, P. Bysted, and S. E. Svehag. Complement C3dg\/Epstein-Barr virus receptor density on human B lymphocytes estimated by immunoenzymatic assay and immunocytochemistry. J. Clin. Lab. Immunol.\n25:153\u2013156 (1988).","journal-title":"J. Clin. Lab. Immunol."},{"key":"303616_CR27","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/eji.1830220504","volume":"22","author":"J. A. Hedrick","year":"1992","unstructured":"J. A. Hedrick, D. Watry, C. Speiser, P. O'Donnell, J. D. Lambris, and C. D. Tsoukas. Interaction between Epstein-Barr virus and a T cell line (HSB-2) via a receptor phenotypically distinct from complement receptor type 2. Eur. J. Immunol.\n22:1123\u20131131 (1992).","journal-title":"Eur. J. Immunol."},{"key":"303616_CR28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0168-1702(88)90084-6","volume":"11","author":"R. Stocco","year":"1988","unstructured":"R. Stocco, G. Sauvageau, and J. Menezes. Differences in Epstein-Barr Virus (EBV) receptors expression on various human lymphoid targets and their significance to EBV-cell interactions. Virus Res.\n11:209\u2013225 (1988).","journal-title":"Virus Res."},{"key":"303616_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1006\/bbrc.1996.5898","volume":"230","author":"I. Muller","year":"1997","unstructured":"I. Muller, A. Jenner, G. Bruchelt, D. Niethammer, and B. Halliwell, Effect of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem. Biophys. Res. Commun.\n230:254\u2013257 (1997).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"303616_CR30","unstructured":"R. K. Prakash, C. M. Clemens, C. D. Ebert, V. Omelyanenko, P. Kope\u010dkov\u00e1, and J. Kope\u010dek. Targeting of macromolecular prodrugs to T-lymphocytes. 24th Intern. Symp. Contr. Rel. Bioact. Mater., July 15\u201319, 1997 Stockholm, Sweden; Proceedings, pp. 859\u2013860."}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018975414165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1018975414165\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1018975414165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T07:33:53Z","timestamp":1754033633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1018975414165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1999,7]]}},"alternative-id":["303616"],"URL":"https:\/\/doi.org\/10.1023\/a:1018975414165","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,7]]}}}